Medical Devices China

China Drug Delivery Devices Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

China Drug Delivery Devices Market Industry Trends and Forecast to 2034: Segmented by (Route, Product, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

China · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $4.35 Bn Placeholder estimate
Estimate 2025 $4.74 Bn 9.2% of the global market
Projected 2034 $10.21 Bn 115.4% Adds $5.47 Bn over 9 forecast years
CAGR 2025–2034 8.9% Faster than 39% of 186 Medical Devices markets here
Key players 6 +1
  • China is 9.2% of the global market.
  • In APAC, the largest is China (this report) at $4.74 Bn.
  • Fastest growing: India at 10.4% a year.
  • China ranks 1st of 14 by size in APAC.

Market size projection

China

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$5.47 Bn total, 2026–2034

Year-by-year market size, 2024–2034
Drug Delivery Devices Market market size by year, China
YearMarket sizeChange that yearSince 2025
2024 (estimate) $4.35 Bn — —
2025 (base) $4.74 Bn +$387.2 Mn —
2026 (forecast) $5.16 Bn +$421.7 Mn +8.9%
2027 (forecast) $5.62 Bn +$459.2 Mn +18.6%
2028 (forecast) $6.12 Bn +$500.1 Mn +29.1%
2029 (forecast) $6.66 Bn +$544.6 Mn +40.6%
2030 (forecast) $7.26 Bn +$593.0 Mn +53.2%
2031 (forecast) $7.90 Bn +$645.8 Mn +66.8%
2032 (forecast) $8.61 Bn +$703.3 Mn +81.6%
2033 (forecast) $9.37 Bn +$765.9 Mn +97.8%
2034 (forecast) $10.21 Bn +$834.0 Mn +115.4%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

China Drug Delivery Devices Market Analysis at a glance
Market size, 2025$4.74 Bn placeholder estimate
Forecast, 2034$10.21 Bn placeholder estimate
Growth (CAGR), 2025–20348.9% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsRoute and product (see all)
Key playersBD (Becton, Dickinson), Gerresheimer, West Pharmaceutical Services, Ypsomed, Terumo Corporation and 1 more (see all)
Regulator in ChinaNMPASource: National Medical Products Administration. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The China Drug Delivery Devices Market Analysis Executive Summary

Drug delivery devices give medicine in a controlled way, such as injectors, inhalers, patches and infusion pumps.

Key segments of the drug delivery devices market include route (Injectable, Inhalation and Transdermal) and product (Auto-Injectors, Pen Injectors and Inhalers).

Bar chart: China Drug Delivery Devices market size, 2024–2034, placeholder estimates. $4.35 Bn in 2024, $4.74 Bn in 2025 and $10.21 Bn in 2034, 8.9% CAGR.
China Drug Delivery Devices market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

China Drug Delivery Devices Market Dynamics

Market Growth Drivers

Rising numbers of people with diabetes, a shift to tools that track and deliver treatment automatically, and more insurance cover are driving the drug delivery devices market.

Opportunity

Connected devices, lower-priced sensors and new insulins and pills give the drug delivery devices market room to grow.

Market Restraints

High costs for people without cover, price competition and uneven access to care in low-income countries hold back the drug delivery devices market.

Competitive Landscape for Drug Delivery Devices Market in China

The drug delivery devices market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Drug Delivery Devices Market in China

Drug Delivery Devices in China: rules and payment

Medical devices are regulated by the National Medical Products Administration (NMPA) and its provincial offices: class I devices are filed, and class II and III devices are registered.⁠[1] Basic medical insurance covers most people; the National Healthcare Security Administration (NHSA) runs it and sets the National Reimbursement Drug List.⁠[2]

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how drug delivery devices products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in China.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Drug Delivery Devices right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 21 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Drug Delivery Devices in context

China compared

  • Health spending per person: 763 US$ per person (2023). World: 1,317 US$ per person (2023). 6th highest of the 17 countries we cover in APAC.[1]
  • Doctors: 3.11 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). 3rd highest of the 17 countries we cover in APAC.[2]
  • People aged 65 and over: 14.9% of people (2025). World: 10.4% of people (2025). 7th highest of the 18 countries we cover in APAC.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 20 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 20 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 21 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Drug Delivery Devices market in China?
Placeholder estimate: about $4.74 Bn in 2025, rising to about $10.21 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Drug Delivery Devices market in China growing?
Placeholder estimate: about 8.9% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Drug Delivery Devices market report cover?
The report splits the market by route (Injectable, Inhalation, Transdermal, Ocular and more) and product (Auto-Injectors, Pen Injectors, Inhalers, Infusion Pumps).
Who are the key players in the Drug Delivery Devices market?
Key players include BD (Becton, Dickinson), Gerresheimer, West Pharmaceutical Services, Ypsomed, Terumo Corporation and Baxter International.
What is driving the Drug Delivery Devices market?
Rising numbers of people with diabetes, a shift to tools that track and deliver treatment automatically, and more insurance cover are driving the drug delivery devices market.
Who regulates Drug Delivery Devices in China?
Medical devices are regulated by the National Medical Products Administration (NMPA) and its provincial offices: class I devices are filed, and class II and III devices are registered. Source: National Medical Products Administration. Checked 14 Nov 2026.
How is healthcare paid for in China?
Basic medical insurance covers most people; the National Healthcare Security Administration (NHSA) runs it and sets the National Reimbursement Drug List. Source: National Healthcare Security Administration. Checked 14 Nov 2026.
How much research is published on Drug Delivery Devices?
PubMed lists 303 papers on Drug Delivery Devices added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 21 Nov 2026.
Back to Catalogue

Related Medical Devices reports in China

See all

Related on drug development and manufacturing

See the topic